Circulating Monocyte-Platelet Aggregates Are a More Sensitive Marker of In Vivo Platelet Activation Than Platelet Surface P-Selectin: Studies in Baboons, Human Coronary Intervention, and Human Acute…

By Alan D. Michelson, M. Barnard, Lori A. Krueger, C. Valeri, M. Furman. Circulation, 2001

762 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Hematology, Oncology

View Paper: https://www.semanticscholar.org/paper/bd737daa0276f98b8c6a9d87ab23efd590a61984

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. H. Langer
2. P. Seizer
3. Henry Nording

In Hematology

1. A. Poole
2. Ewelina Gołębiewska

In Oncology

1. A. Poole
2. Ewelina Gołębiewska

Citations in the corpus

• Platelets in Inflammation and Atherogenesis (2015, background): “PLATELET CONTRIBUTION TO ATHEROSCLEROSIS In atherosclerosis, platelets are known to contribute to early steps of this chronic vascular pathology (Figure 2) such as endothelial dysfunction (101, 102), but also to final events such as rupture of the vulnerable plaque [(103), see also Figure 4].”
• Circulating Platelets as Mediators of Immunity, Inflammation and Thrombosis (2018, methodology): “Platelet–monocyte aggregates may be a more sensitive method for assessing platelet activation when compared with P-selectin expression.(70) Circulating platelet–monocyte aggregates are elevated in patients with acute myocardial infarction,(71,72) and, in older patients, platelet–monocyte aggregates ”